# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001125345-22-000040
Filing Date
2022-04-08
Accepted
2022-04-08 16:07:25
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14a_2022.htm | DEFA14A | 11726
2 |  | macrogenicsnaa22final_page.jpg | GRAPHIC | 1338555
3 |  | macrogenicsnaa22final_pagea.jpg | GRAPHIC | 124912
| Complete submission text file | 0001125345-22-000040.txt |  | 2026526

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36112 | Film No.: 22817045
SIC: 2834 Pharmaceutical Preparations